Every trade that managers of Ortho Regenerative Technologies Inc. disclose to SEDI is tracked on this page. Nothing new has been filed by managers of Ortho Regenerative Technologies Inc. in twelve months, the latest record being from 2 June 2022.
Looking back to 2016, when coverage begins, insiders filed 51 purchases and 20 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 104 declarations
Ortho Regenerative Technologies Inc. is a company focused on developing tissue regeneration solutions for orthopedic applications. It is listed on the XTSE market.